Related Experiment Video
Updated: Dec 12, 2025

Intense Pulsed Light for the Treatment of Dry Eye Owing to Meibomian Gland Dysfunction
Published on: April 1, 2019
[Keratoconjunctivitis photoelectrica (arc eye)]
Brahim Salem Joumany1, Sidi Dahi1, Mahdi Khamaily1
1Service d'Ophtalmologie, Hôpital Militaire d'Instruction Mohammed V, Faculté de Médecine et de Pharmacie, Université Mohammed V, Rabat, Maroc.
Abstract:
Photokeratitis is a painful keratitis caused by exposure of insufficiently protected eyes to the ultraviolet (UV) rays. We talk about "arc eye" when photokeratitis is caused by UV rays emitted by electric arc during electric arc welding process. We here report the case of a 35-year old rider, with no previous medical-surgical history, who had looked at an electric arc for a few minutes while the doors of his building were welded. He had bilateral burning in his eyes associated with lacrimation, photophobia and blepharospasm. Clinical examination showed corrected visual acuity of 8/10 and 9/10, conjunctival hyperemia with punctate erosive keratitis limited to palpebral fissure after the use of fluorescein. Given patient's clinical picture, keratoconjunctivitis photoelectrica (arc eye) was diagnosed. Treatment was based on topical antibiotics, wetting agents as well as agents with healing properties. Outcome was marked by total disappearance of the signs with restoration of bilateral visual acuity (10/10). This study highlights the role of prevention using appropriate protection equipment.
More Related Videos
09:20Novel Photoacoustic Microscopy and Optical Coherence Tomography Dual-modality Chorioretinal Imaging in Living Rabbit Eyes
Published on: February 8, 2018
07:36Clinical Application of Intense Pulsed Light Therapy and Radio Frequency for Treatment of Ocular Surface Diseases
Published on: July 3, 2025
Related Concept Videos
Focusing of Light in the Eye
Angle Closure Glaucoma: Treatment
Photoelectric Effect
Photoreceptors and Visual Pathways
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Glaucoma: Overview